e-learning
resources
Amsterdam 2011
Sunday, 25.09.2011
Rare diffuse lung diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Extracellular concentration and enzyme activity of proteasome in BAL of patients with alveolar proteinosis
F. Bonella, T. Anlasik, J. C. Thomassen, M. Cai, S. Ohshimo, J. Guzman, U. Costabel (Essen, Düsseldorf, Bochum, Germany; Hiroshima, Japan)
Source:
Annual Congress 2011 - Rare diffuse lung diseases
Session:
Rare diffuse lung diseases
Session type:
Thematic Poster Session
Number:
628
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
F. Bonella, T. Anlasik, J. C. Thomassen, M. Cai, S. Ohshimo, J. Guzman, U. Costabel (Essen, Düsseldorf, Bochum, Germany; Hiroshima, Japan). Extracellular concentration and enzyme activity of proteasome in BAL of patients with alveolar proteinosis. Eur Respir J 2011; 38: Suppl. 55, 628
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Pulmonary sarcoidosis
Definition and history of sarcoidosis
Related content which might interest you:
Determinants of protein concentration in whole lung lavage of patients with pulmonary alveolar proteinosis
Source: Annual Congress 2009 - From genetics to clinics in diffuse parenchymal lung diseases
Year: 2009
Detection of extracellular proteasome in the human alveolar space
Source: Annual Congress 2006 - Molecular airway biology
Year: 2006
Serum and BALF levels of YKL-40 in patients with alveolar proteinosis
Source: Annual Congress 2010 - Biomarkers in diffuse parenchymal lung disease
Year: 2010
Differences in the immunolocalization of surfactant protein (SP)-A, SP-D and KL-6 in pulmonary alveolar proteinosis
Source: Annual Congress 2008 - Miscellaneous aspects of interstitial lung disease
Year: 2008
KL-6 in whole lung lavage fluid of patients with pulmonary alveolar proteinosis
Source: Annual Congress 2009 - Sarcoidosis and profiles of other diffuse parenchymal lung disease
Year: 2009
Lysosomal iron in pulmonary alveolar proteinosis: a case report
Source: Eur Respir J 2009; 33: 673-679
Year: 2009
Elevated level of tissue inhibitor of metalloproteinase 1 in bronchoalveolar lavage fluid in fibrosing lung diseases
Source: Eur Respir J 2002; 20: Suppl. 38, 313s
Year: 2002
Surfactant proteins in pulmonary alveolar proteinosis in adults
Source: Eur Respir J 2004; 24: 426-435
Year: 2004
Role of secretory leukocyte protease inhibitor in the development of subclinical emphysema
Source: Eur Respir J 2002; 19: 1050-1057
Year: 2002
Abnormal intraalveolar accumulation of surfactant proteins in adults with pulmonary alveolar proteinosis
Source: Eur Respir J 2002; 20: Suppl. 38, 90s
Year: 2002
Pulmonary alveolar proteinosis
Source: Respipedia Article
Year: 2017
Glutamate-cysteine ligase modulatory subunit in BAL alveolar macrophages of healthy smokers
Source: Eur Respir J 2003; 22: 82-87
Year: 2003
Mini-whole lung lavage to treat pulmonary alveolar proteinosis (PAP)
Source: Virtual Congress 2020 – Addressing unresolved questions in rare diffuse parenchymal lung diseases: interdisciplinary research is the key
Year: 2020
Iron and lipid content in serum and alveolar macrophages obtained by bronchoalveolar lavage in experimental pulmonary emphysema
Source: Eur Respir J 2001; 18: Suppl. 33, 414s
Year: 2001
Increased production of caspase-1 by alveolar macrophages in patients with pulmonary sarcoidosis
Source: Eur Respir J 2002; 20: Suppl. 38, 585s
Year: 2002
Haemoxygenase-1 expression in broncho-alveolar lavage fluid alveolar macrophages is diminished in patients with COPD
Source: Eur Respir J 2002; 20: Suppl. 38, 404s
Year: 2002
Whole lung lavage (WLL) for patients with pulmonary alveolar proteinosis
Source: Eur Respir J 2004; 24: Suppl. 48, 670s
Year: 2004
Surfactant protein C proprotein, chitotriosidase and RAGE in bronchoalveolar lavage fluid of children with sarcoidosis
Source: Annual Congress 2010 - Biomarkers in diffuse parenchymal lung disease
Year: 2010
Levels of proteinase 3 and neutrophil elastase in plasma, BAL and biopsies in COPD
Source: Virtual Congress 2020 – Novel immunopathological mechanisms of lung disease: knowledge from translational studies
Year: 2020
The value of the whole lung lavage for patients with pulmonaryalveolar proteinosis
Source: Annual Congress 2009 - Trends in bronchoscopy
Year: 2009
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept